Studies brain function and illness course in children with severe mood problems
Observes children and teens with severe mood dysregulation using testing and brain imaging.
Key facts
- Who runs it
- National Institute of Mental Health (NIMH)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Studies of Brain Function and Course of Illness in Pediatric Bipolar Disorder
- Status
- Recruiting
- People taking part
- 2,350 people, planned
- Started
- 1 Jan 2002
- Type of study
- Observational, 6 groups
- Treatments tested
- Lithium
- Record updated
- 23 September 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for children and teens with severe mood problems (DMDD or subthreshold DMDD), plus some children with depression or ADHD, caregivers and healthy volunteers for comparison.
- Age
- 7 Years to 85 Years. Children with DMDD: 7-17. Children with depression: 11-17. Children with ADHD: 8-17.
- Sex
- All
- Disease stage
- Children with DMDD have angry, sad or irritable mood on most days for at least 12 months, with severe temper outbursts, starting before age 10. Others: major depressive disorder or ADHD.
Main reasons for not taking part
- Signs of bipolar disorder, such as elevated mood or less need for sleep
- IQ under 70
- Pregnant or breastfeeding
- Alcohol or drug abuse in the last three months
- Schizophrenia-type illness, PDD or PTSD
The registry criteria, word for word
Show all 14 criteriaShow less
Who cannot take part
- Exclusion of caregivers of children and adolescents with DMDD or subthreshold DMDD; 2.1 Have an I.Q. < 70; 2.2 Have any serious medical condition or condition that interferes with participation; 3.2 Healthy Volunteer (Control) Children:; 3.2.1. I.Q. < 70; 3.2.2. Any serious medical condition or condition that interferes with fMRI or MEG/EEG scanning, or fNIRS, pregnant or lactating; 3.2.3. Past or current diagnosis of any anxiety disorder (panic disorder, GAD, Separation Anxiety Disorder, Social Phobia), mood disorder (manic or hypomanic episode, major depression), OCD, PTSD, Conduct Disorder, psychosis, current suicidal ideation, Tourette Disorder, Autism Spectrum Disorder or ADHD; 3.2.4. Substance abuse within two months prior to study participation or present substance abuse; 3.2.5. History of sexual abuse; 3.2.6. Parent or sibling with Bipolar Disorder, recurrent MDD, or any disorder with psychosis; 4.2 Healthy Volunteer Adults:; 4.2.1. IQ< 70; 4.2.2. Pregnant; 4.2.3. Any past or current history of Bipolar Disorder (any manic or hypomanic episode), recurrent MDD, or any disorder with psychosis; 5.3 Exclusion criteria for those with MDD:; 5.3.1 The individual exhibits any of these cardinal bipolar symptoms:; 5.3.1.1 Elevated or expansive mood; 5.3.1.2 Grandiosity or inflated self-esteem; 5.3.1.3 Decreased need for sleep; 5.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences); 5.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day; 5.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD; 5.3.3. IQ< 70; 5.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition; 5.3.5. Currently pregnant or lactating; 5.3.6. Meets criteria for alcohol or substance abuse with the last three months; 6.2. Exclusion criteria for those with ADHD:; 6.2.1. IQ<70; 6.2.2. Pregnancy; 6.2.3. Ongoing medical illness or neurological disorder other than ADHD; 6.2.4. Any condition that would interfere with the participants' ability to perform research tasks; 6.2.5. Current Major Depression; 6.2.6. Any past or present manic or hypomanic episode
- 1.3.2. Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, PDD, or PTSD
- 1.3.4. The symptoms are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition
- 1.3 Exclusion criteria for those with DMDD:
- 1.3.1 The individual exhibits any of these cardinal bipolar symptoms:
- 1.3.1.1 Elevated or expansive mood
- 1.3.1.2 Grandiosity or inflated self-esteem
- 1.3.1.3 Decreased need for sleep
- 1.3.1.4 Increase in goal-directed activity (this can result in the excessive involvement in pleasurable activities that have a high potential for painful consequences)
- 1.3.1.5. Has BD symptoms in distinct periods lasting more than 1 day
- 1.3.3. IQ< 70
- 1.3.5. Currently pregnant or lactating
- 1.3.6. Meets criteria for alcohol or substance abuse with the last three months
Other criteria
- INCLUSION CRITERIA:; Inclusion criteria for children with DMDD, subthreshold DMDD:; 1.1.1 Ages 7-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25; 1.1.2 Abnormal mood (specifically, anger, sadness, and/or irritability), present at least half of the day most days (or at least half the day at least one day per week for subthreshold), and of sufficient severity to be noticeable by people in the child's environment (e.g. parents/caregivers, teachers, peers); 1.1.3 Compared to his/her peers, the child exhibits markedly increased reactivity to negative emotional stimuli that is manifest verbally or behaviorally. For example, the child responds to frustration with extended temper tantrums (inappropriate for age and/or precipitating event), verbal rages, and/or aggression toward people or property. Such events occur, on average, at least three times a week. For subthreshold DMDD such tantrums occur on average at least once per month; 1.1.4 The symptoms in # 1.1.2, and 1.1.3 above are currently present and have been present for at least 12 months without any symptom-free periods exceeding three months; 1.1.5 The onset of symptoms must be prior to age 10 years; 1.1.6 For DMDD the symptoms are severe in at least in one setting (e.g. violent outbursts, assaultiveness at home, school, or with peers) and at least mild (distractibility, intrusiveness) in a second setting. For subthreshold DMDD, there must be evidence of impairment causing distress to the child or to those around him/her in at least one setting; Caregivers of children and adolescents with DMDD or subthreshold DMDD enrolled in 02-M-0021; 2.1.1. Are capable of performing behavioral tasks and/or scanning; 2.1.2. Speaks English; Healthy Volunteer (Control) Children; 3.1.1. Control subjects will be group matched to the patients; 3.1.2. Have an identified primary care physician; 3.1.3. Speaks English; Healthy Volunteer Adults; 4.1.1 Control subjects will be group matched to the patients; 4.1.2. They will have normal physical and neurological examinations by history or checklist; 4.1.3. Have an identified primary care physician; 4.1.4 Speaks English; Children with Major Depressive Disorder (MDD) Inclusion criteria (all must be met):; 5.1.1 Ages 11-17 at the time of recruitment; will be followed in the longitudinal component of the study until age 25; 5.1.2. DSM-IV or DSM-5 Major Depressive Disorder; 5.1.2.1 Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure; 5.1.2.1.1 Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps," or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.); 5.1.2.1.2 Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing; 5.1.2.1.3. Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month), or decrease or increase in appetite nearly every day; 5.1.2.1.4. Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day; 5.1.2.1.5. Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day; 5.1.2.1.6. Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual); 5.1.2.1.7. Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings); 5.1.2.1.8. Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g. appears easily distracted, complains of memory difficulties); 5.1.2.1.9. Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide; 5.1.2.1.10 Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning; 5.1.2.1.11. The episode is not attributable to the physiological effects of a substance or to another medical condition; 5.1.3. Youth with MDD who are continuing in research as adults must also be receiving psychiatric care for their MDD, if it is ongoing; Children with Attention-Deficit/Hyperactivity Disorder (ADHD); 6.1.1. Age 8-17; 6.1.2. Currently meets DSM-IV or DSM-5 criteria for ADHD; 6.1.3. Subjects with other primary psychiatric disorders including anxiety disorders, dysthymic disorder, past major depression, oppositional defiant disorder, tic disorders, and the learning, communication, and elimination disorders may be accepted; 6.1.4. Have an identified primary care physician; 6.1.5. Speaks English
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 7 and 85 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Melissa A Brotman, Ph.D.Taking people
About the trial
What the trial wants to find out
This study seeks to learn more about the symptoms of severe mood dysregulation in children and adolescents ages 7-17. Children and adolescents with severe mood dysregulation (SMD) display chronic anger, sadness, or irritability, as well as hyperarousal (such as insomnia, distractibility, hyperactivity) and extreme responses to frustration (such as frequent, severe temper tantrums). Researchers will describe the moods and behaviors of children with these symptoms and use specialized testing and brain imaging to learn about the brain changes associated with this disorder.
The 6 groups in the trial
- Children/adolescents with ADHD
Treatment: Lithium
- Children/Adolescents with DMDD or subthreshold DMDD
Treatment: Lithium
- Children/adolescents with MDD
- Healthy volunteer adults
- Healthy volunteer children/adolescents
- Parents of children/adolescents with DMDD or subthreshold DMDD
Parents of children/adolescents with DMDD or subthresdhold DMDD
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Characterization and Pathophysiology of Severe Mood and Behavioral Dysregulation in Children and Youth
- Plain-language title
- Studies brain function and illness course in children with severe mood problemsGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT00025935, who can take part
- Publications
- Modeling Shared and Specific Variances of Irritability, Inattention, and Hyperactivity Yields Novel Insights Into White Matter Perturbations.Journal of the American Academy of Child and Adolescent Psychiatry, 2024
- Network analysis of ecological momentary assessment identifies frustration as a central node in irritability.Journal of child psychology and psychiatry, and allied disciplines, 2023
- Real-time assessment of positive and negative affective fluctuations and mood lability in a transdiagnostic sample of youth.Depression and anxiety, 2022
- Understanding Irritability in Relation to Anger, Aggression, and Informant in a Pediatric Clinical Population.Journal of the American Academy of Child and Adolescent Psychiatry, 2022
- Functional connectivity during frustration: a preliminary study of predictive modeling of irritability in youth.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2021
- Computational Modeling of Attentional Impairments in Disruptive Mood Dysregulation and Attention-Deficit/Hyperactivity Disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 2021
- Shared and Anxiety-Specific Pediatric Psychopathology Dimensions Manifest Distributed Neural Correlates.Biological psychiatry, 2021
- White Matter Microstructure in Pediatric Bipolar Disorder and Disruptive Mood Dysregulation Disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 2020
- Neural mechanisms of face emotion processing in youths and adults with bipolar disorder.Bipolar disorders, 2019
- Brain Mechanisms of Attention Orienting Following Frustration: Associations With Irritability and Age in Youths.The American journal of psychiatry, 2019
- Record updated
- 23 September 2026